Currently out of the existing stock ratings of Yanan Zhu, 82 are a BUY (77.36%), 24 are a HOLD (22.64%).

Yanan Zhu

Work Performance Price Targets & Ratings Chart

Analyst Yanan Zhu, currently employed at WELLS FARGO, carries an average stock price target met ratio of 40.64% that have a potential upside of 57.65% achieved within 87 days.

Yanan Zhu’s has documented 212 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARCT, Arcturus Therapeutics Holdings at 22-Oct-2025.

Wall Street Analyst Yanan Zhu

Analyst best performing recommendations are on RGLS (REGULUS THERAPEUTICS).
The best stock recommendation documented was for RGLS (REGULUS THERAPEUTICS) at 3/27/2025. The price target of $6 was fulfilled within 34 days with a profit of $4.5 (300%) receiving and performance score of 88.24.

Average potential price target upside

ARGX argenx NV ADR EDIT Editas Medicine RAPT RAPT Therapeutics AVRO AVROBIO BLUE Bluebird bio SGMO Sangamo Therapeutics AGLE Aeglea Bio Therapeutics AGTC Applied Genetic TSHA Taysha Gene Therapies  BEAM Beam Therapeutics  NTLA Intellia Therapeutics AFMD Affimed NV AUTL Autolus Therapeutics Ltd FATE Fate Therapeutics IOVA Iovance Biotherapeutics RNA Avidity Biosciences  GRCL Gracell Biotechnologies TCRT Alaunos Therapeutics IONS Ionis Pharmaceuticals SYRE Spyre Therapeutics ARCT Arcturus Therapeutics Holdings CCXI ChemoCentryx MNTA Momenta Pharmaceuticals QURE Uniqure NV RGLS Regulus Therapeutics SRPT Sarepta Therapeutics VYGR Voyager Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$880

$62.68 (7.67%)

$715

18 days ago
(12-Oct-2025)

19/20 (95%)

$80.44 (10.06%)

123

Buy

$1040

$222.68 (27.25%)

$750

30 days ago
(30-Sep-2025)

20/21 (95.24%)

$272.67 (35.53%)

190

Buy

$1070

$252.68 (30.92%)

$1065

1 months 13 days ago
(17-Sep-2025)

12/15 (80%)

$338.23 (46.22%)

155

Buy

$887

$69.68 (8.53%)

$607

1 months 29 days ago
(01-Sep-2025)

6/7 (85.71%)

$180.59 (25.56%)

242

Buy

$830

$12.68 (1.55%)

$805

2 months 27 days ago
(03-Aug-2025)

15/15 (100%)

$139.68 (20.23%)

210

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yanan Zhu is most bullish on?

Potential upside of $42.04 has been obtained for BEAM (BEAM THERAPEUTICS )

Which stock is Yanan Zhu is most reserved on?

Potential downside of $0.28 has been obtained for EDIT (EDITAS MEDICINE)

What Year was the first public recommendation made by Yanan Zhu?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?